SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF, et al.Interstitial lung disease in polymyositis and dermatomyositis.Arthritis Rheum2002;47:61422.
  • 2
    Connors GR, Christopher-Stine L, Oddis CV, Danoff SK.Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?Chest2010;138:146474.
  • 3
    Morinishi Y, Oh-Ishi T, Kabuki T, Joh K.Juvenile dermatomyositis: clinical characteristics and the relatively high risk of interstitial lung disease.Mod Rheumatol2007;17:4137.
  • 4
    Rider LG.The heterogeneity of juvenile myositis.Autoimmun Rev2007;6:2417.
  • 5
    Targoff IN.Autoantibodies and their significance in myositis.Curr Rheumatol Rep2008;10:33340.
  • 6
    Gunawardena H, Betteridge ZE, McHugh NJ.Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression.Rheumatology (Oxford)2009;48:60712.
  • 7
    Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Gorza L, Doria A.Cutting edge issues in polymyositis.Clin Rev Allergy Immunol2010;41:17989.
  • 8
    Kalluri M, Oddis CV.Pulmonary manifestations of the idiopathic inflammatory myopathies.Clin Chest Med2010;31:50112.
  • 9
    Sanner H, Aalokken TM, Gran JT, Sjaastad I, Johansen B, Flato B.Pulmonary outcome in juvenile dermatomyositis: a case-control study.Ann Rheum Dis2011;70:8691.
  • 10
    Wedderburn LR, Rider LG.Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.Best Pract Res Clin Rheumatol2009;23:66578.
  • 11
    Morganroth PA, Kreider ME, Okawa J, Taylor L, Werth VP.Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations.Arch Dermatol2010;146:72938.
  • 12
    Fathi M, Lundberg IE.Interstitial lung disease in polymyositis and dermatomyositis.Curr Opin Rheumatol2005;17:7016.
  • 13
    Trapani S, Camiciottoli G, Vierucci A, Pistolesi M, Falcini F.Pulmonary involvement in juvenile dermatomyositis: a two-year longitudinal study.Rheumatology (Oxford)2001;40:21620.
  • 14
    Fathi M, Vikgren J, Boijsen M, Tylen U, Jorfeldt L, Tornling G, et al.Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology.Arthritis Rheum2008;59:67785.
  • 15
    Vega P, Ibarra M, Prestridge A, Pachman LM.Autoantibody to PL-12 (anti-alanyl-tRNA synthetase) in an African American girl with juvenile dermatomyositis and resolution of interstitial lung disease [letter].J Rheumatol2011;38:3945.
  • 16
    Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM.Disease Activity Score for children with juvenile dermatomyositis: reliability and validity evidence.Arthritis Rheum2003;49:715.
  • 17
    Ruperto N, Ravelli A, Pistorio A, Ferriani V, Calvo I, Ganser G, et al, for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study.Arthritis Rheum2008;59:413.
  • 18
    Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, et al, in cooperation with the Juvenile Dermatomyositis Disease Activity Collaborative Study Group.Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function.Arthritis Rheum1999;42:22139.
  • 19
    Pachman LM, Abbott K, Sinacore JM, Amoruso L, Dyer A, Lipton R, et al.Duration of illness is an important variable for untreated children with juvenile dermatomyositis.J Pediatr2006;148:24753.
  • 20
    Ibarra MF, Klein-Gitelman M, Morgan E, Proytcheva M, Sullivan C, Morgan G, et al.Serum neopterin levels as a diagnostic marker of hemophagocytic lymphohistiocytosis syndrome.Clin Vaccine Immunol2011;18:60914.
  • 21
    Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al.Standardisation of spirometry.Eur Respir J2005;26:31938.
  • 22
    Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al.Standardisation of the single-breath determination of carbon monoxide uptake in the lung.Eur Respir J2005;26:72035.
  • 23
    Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al.Standardisation of the measurement of lung volumes.Eur Respir J2005;26:51122.
  • 24
    Bohan A.History and classification of polymyositis and dermatomyositis.Clin Dermatol1988;6:38.
  • 25
    Pachman LM, Cooke N.Juvenile dermatomyositis: a clinical and immunologic study.J Pediatr1980;96:22634.
  • 26
    Rider LG, Miller FW, Targoff IN, Sherry DD, Samayoa E, Lindahl M, et al.A broadened spectrum of juvenile myositis: myositis-specific autoantibodies in children.Arthritis Rheum1994;37:15348.
  • 27
    Betteridge ZE, Gunawardena H, McHugh NJ.Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.Arthritis Res Ther2011;13:209.
  • 28
    Chen YJ, Wu CY, Shen JL.Predicting factors of interstitial lung disease in dermatomyositis and polymyositis.Acta Derm Venereol2007;87:338.
  • 29
    Labirua A, Lundberg IE.Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls.Curr Opin Rheumatol2010;22:6338.
  • 30
    Feldman BM, Reichlin M, Laxer RM, Targoff IN, Stein LD, Silverman ED.Clinical significance of specific autoantibodies in juvenile dermatomyositis.J Rheumatol1996;23:17947.
  • 31
    Wedderburn LR, McHugh NJ, Chinoy H, Cooper RG, Salway F, Ollier WE, et al.HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.Rheumatology (Oxford)2007;46:178691.
  • 32
    Hengstman GJ, Vree Egberts WT, Seelig HP, Lundberg IE, Moutsopoulos HM, Doria A, et al.Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 β antigen.Ann Rheum Dis2006;65:2425.
  • 33
    Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O'Hanlon TP, et al, for the Childhood Myositis Heterogeneity and International Myositis Collaborative Study Groups.A novel autoantibody to a 155-kd protein is associated with dermatomyositis.Arthritis Rheum2006;54:36829.
  • 34
    Labrador-Horrillo M, Martinez MA, Selva-O'Callaghan A, Trallero-Araguas E, Balada E, Vilardell-Tarres M, et al.Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays.Ann Rheum Dis2012;71:9936.
  • 35
    Ibarra M, Chou P, Pachman LM.Ovarian teratoma mimicking features of juvenile dermatomyositis in a child.Pediatrics2011;128:e12936.
  • 36
    Balboni I, Niewold T, Morgan GA, Limb C, Eloranta ML, Utz P, et al.Concordance of serologic data in juvenile dermatomyositis: interferon-α induction and activity, and detectable levels of anti-Ro and anti-La autoantibodies [abstract].Clin Immunol2009;131:s134.
  • 37
    Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L.The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study.J Am Acad Dermatol2011;65:2534.
  • 38
    Songcharoen S, Raju SF, Pennebaker JB.Interstitial lung disease in polymyositis and dermatomyositis.J Rheumatol1980;7:35360.
  • 39
    Nagai Y, Mizuno T, Yoshizawa C, Ishikawa O.Fatal interstitial pneumonia in juvenile dermatomyositis.Eur J Dermatol2010;20:20810.
  • 40
    Saito M, Chihara J, Mouri T, Kurachi D, Yamamoto T, Nakajima S.Elevated local production of neopterin from alveolar macrophages in patients with internal lung diseases.Gen Pharmacol1996;27:4836.
  • 41
    Gunawardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, Chinoy H, et al.Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis.Rheumatology (Oxford)2008;47:3248.
  • 42
    Guglielmi S, Merz TM, Gugger M, Suter C, Nicod LP.Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus.Eur Respir J2008;31:2137.
  • 43
    Kobayashi I, Yamada M, Takahashi Y, Kawamura N, Okano M, Sakiyama Y, et al.Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A.Rheumatology (Oxford)2003;42:3714.
  • 44
    Camp AV, Lane DJ, Mowat AG.Dermatomyositis with parenchymal lung involvement.Br Med J1972;1:1556.